Imagine switching to different GLP-1 agonists that havent been wiped out, or buddying up with new therapeutic routes
Moreover, that hypothesis (James et al., 1999) has been revised and implemented over the years, leading researchers to hypothesize that maternal polymorphisms of genes involved in folate metabolism could not only favor chromosome 21 malsegregation but, when transmitted to a DS embryo, could also account for the probability that it will survive up to the birth (Martnez-Fras et al., 2006), or contribute to the onset of congenital defects (Brandalize et al., 2009
Which raises an obvious point: if a medication is changing your blood pressure, your glucose, your lipids, and your kidney markers, the person prescribing it should be the same person managing your blood pressure, glucose, lipids, and kidney function
Lifestyle/diet optimization : Alongside supplements, emphasize high-fiber whole-food diet, lean protein, healthy fats, regular physical activity, stress management, sleep